Skip to content

LOVAFARMA: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

LOVAFARMA

BE 0476.540.511
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€411,577
2024 · €137,154+€274,423
Equity
€903,035
2024 · €491,458+€411,577
Cash
€261,639
2024 · €165,785+€95,855
Balance sheet total
€1.6m
2024 · €715,998+€887,581

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€932,099

    up €932,099 (+301.7%), from €308,905 to €1.2m

    of which Land and buildings: +€932,198

  • Cash +€95,855

    up €95,855 (+57.8%), from €165,785 to €261,639

    mainly Net result for the year (+€411,577) and Debts after one year (+€287,944)

  • Deferred charges and accrued income -€78,775

    down €78,775 (-99.0%), from €79,581 to €806

  • Receivables within one year -€60,797

    down €60,797 (-37.8%), from €160,808 to €100,011

    of which Other amounts receivable: -€153,926

Equity and liabilities
  • Reserves +€453,963

    up €453,963 (+221.2%), from €205,194 to €659,156

    of which Tax-exempt reserves: +€453,963

  • Debts after one year +€287,944

    up €287,944, from €0 to €287,944

  • Provisions +€151,321

    up €151,321 (+316.7%), from €47,778 to €199,099

  • Other debts +€68,187

    up €68,187 (+121.9%), from €55,923 to €124,111

  • Current portion of long-term debt -€64,541

    down €64,541 (-86.2%), from €74,906 to €10,365

Income statement
  • Gross operating margin +€465,427

    up €465,427 (+212.4%), from €219,175 to €684,602

  • Depreciation +€84,160

    up €84,160 (+379.1%), from €22,199 to €106,359

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €137,154
Gross operating margin +€465,427
Depreciation -€84,160
Other operating charges -€3,678
Financial income -€533
Financial charges +€1,013
Taxes -€102
Deferred taxes and other -€103,543
Result 2025 €411,577

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€910,096
Investment -€1.0m
Financing +€223,416
Cash 2024 €165,785
Net result for the year +€411,577
Depreciation +€106,359
Receivables within one year +€60,797
Deferred charges and accrued income +€78,775
Provisions +€151,321
Trade debts +€31,035
Tax, wage and social debts -€835
Other debts +€68,187
Accrued charges and deferred income +€2,880
Investment in fixed assets (net) -€1.0m
Debts after one year +€287,944
Current portion of long-term debt -€64,541
Short-term financial debts +€13
Cash 2025 €261,639
Every line side by side 56 lines
Line Code 2024 2025 Change %
Total assets 20/58 €715,998 €1,603,579 +€887,581 +124.0%
Fixed assets 21/28 €309,825 €1,241,123 +€931,299 +300.6%
Tangible fixed assets 22/27 €308,905 €1,241,003 +€932,099 +301.7%
Land and buildings 22 €306,479 €1,238,677 +€932,198 +304.2%
Plant, machinery and equipment 23 €0 €1,560 +€1,560
Furniture and vehicles 24 €2,426 €766 -€1,660 -68.4%
Financial fixed assets 28 €920 €120 -€800 -87.0%
Current assets 29/58 €406,174 €362,456 -€43,718 -10.8%
Stocks and contracts in progress 3 €0 - =
Stocks 30/36 €0 - =
Amounts receivable within one year 40/41 €160,808 €100,011 -€60,797 -37.8%
Trade receivables 40 €6,862 €99,990 +€93,128 +1357.1%
Other amounts receivable 41 €153,946 €20 -€153,926 -100.0%
Cash at bank and in hand 54/58 €165,785 €261,639 +€95,855 +57.8%
Deferred charges and accrued income 490/1 €79,581 €806 -€78,775 -99.0%
Total equity and liabilities 10/49 €715,998 €1,603,579 +€887,581 +124.0%
Equity 10/15 €491,458 €903,035 +€411,577 +83.7%
Contributions 10/11 €216,200 €216,200 = 0.0%
Reserves 13 €205,194 €659,156 +€453,963 +221.2%
Non-distributable reserves 130/1 €1,860 €0 -€1,860 -100.0%
Reserves not available under the articles 1311 €1,860 €0 -€1,860 -100.0%
Tax-exempt reserves 132 €143,334 €597,296 +€453,963 +316.7%
Distributable reserves 133 €60,000 €61,860 +€1,860 +3.1%
Profit (loss) carried forward 14 €70,064 €27,679 -€42,386 -60.5%
Provisions and deferred taxes 16 €47,778 €199,099 +€151,321 +316.7%
Deferred taxes 168 €47,778 €199,099 +€151,321 +316.7%
Amounts payable 17/49 €176,763 €501,446 +€324,683 +183.7%
Amounts payable after more than one year 17 €0 €287,944 +€287,944
Financial debts 170/4 €0 €287,944 +€287,944
Amounts payable within one year 42/48 €170,743 €204,602 +€33,859 +19.8%
Current portion of amounts payable after more than one year 42 €74,906 €10,365 -€64,541 -86.2%
Financial debts 43 €87 €100 +€13 +14.9%
Credit institutions 430/8 €87 €100 +€13 +14.9%
Trade debts 44 €30,450 €61,485 +€31,035 +101.9%
Suppliers 440/4 €30,450 €61,485 +€31,035 +101.9%
Taxes, remuneration and social security 45 €9,375 €8,541 -€835 -8.9%
Taxes 450/3 €9,375 €8,541 -€835 -8.9%
Remuneration and social security 454/9 €0 - =
Other amounts payable 47/48 €55,923 €124,111 +€68,187 +121.9%
Accrued charges and deferred income 492/3 €6,020 €8,900 +€2,880 +47.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €22,199 €106,359 +€84,160 +379.1%
Other operating charges 640/8 €4,203 €7,882 +€3,678 +87.5%
Gross operating margin 9900 €219,175 €684,602 +€465,427 +212.4%
Operating profit (loss) 9901 €192,773 €570,361 +€377,588 +195.9%
Financial income 75/76B €746 €213 -€533 -71.4%
Recurring financial income 75 €746 €213 -€533 -71.4%
Financial charges 65/66B €8,513 €7,500 -€1,013 -11.9%
Recurring financial charges 65 €8,513 €7,500 -€1,013 -11.9%
Profit (loss) for the period before taxes 9903 €185,006 €563,074 +€378,068 +204.4%
Transfer from deferred taxes 780 €145 €22,414 +€22,269 +15319.8%
Transfer to deferred taxes 680 €47,923 €173,735 +€125,812 +262.5%
Income taxes 67/77 €74 €176 +€102 +137.6%
Profit (loss) for the period 9904 €137,154 €411,577 +€274,423 +200.1%
Transfer from tax-exempt reserves 789 €436 €67,242 +€66,806 +15320.5%
Transfer to tax-exempt reserves 689 €143,770 €521,205 +€377,435 +262.5%
Profit (loss) for the period to be appropriated 9905 -€6,180 -€42,386 -€36,206 -585.9%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.